Grace Therapeutics, Inc. Quarterly Deferred Tax Assets, Gross in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Grace Therapeutics, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2019 to Q1 2023.
  • Grace Therapeutics, Inc. Deferred Tax Assets, Gross for the quarter ending March 31, 2023 was $51.6M, a 11.1% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $51.6M +$5.16M +11.1% Mar 31, 2023 10-K 2023-06-23
Q1 2022 $46.5M +$7.26M +18.5% Mar 31, 2022 10-K 2023-06-23
Q1 2021 $39.2M +$8.76M +28.8% Mar 31, 2021 10-K 2021-06-22
Q1 2020 $30.5M +$4.49M +17.3% Mar 31, 2020 10-K 2021-06-22
Q1 2019 $26M Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.